Cargando…

Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis

AIMS: JNJ-64179375 (hereafter JNJ-9375) is a first-in-class, highly specific, large molecule, exosite 1 thrombin inhibitor. In preclinical studies, JNJ-9375 demonstrated robust antithrombotic protection with a wider therapeutic index when compared to apixaban. The purpose of the present study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Simon J, Connolly, Thomas M, Peters, Gary, Ghosh, Atalanta, Johnson, Maureen, Newby, David E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383059/ https://www.ncbi.nlm.nih.gov/pubmed/30184110 http://dx.doi.org/10.1093/cvr/cvy227

Ejemplares similares

The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin
por: Chahal, Gurdeep, et al.
Publicado: (2015)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

GpIbα Interacts Exclusively with Exosite II of Thrombin()
por: Lechtenberg, Bernhard C., et al.
Publicado: (2014)

Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
por: Santamaria, Salvatore, et al.
Publicado: (2021)

Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands
por: Troisi, Romualdo, et al.
Publicado: (2021)

Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition
por: Cuffaro, Doretta, et al.
Publicado: (2022)

Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity
por: Fan, Yongfeng, et al.
Publicado: (2015)

The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand
por: Boyle, Amanda J, et al.
Publicado: (2013)

Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity
por: Dólleman, Sophie C., et al.
Publicado: (2022)

Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)
por: Santamaria, Salvatore, et al.
Publicado: (2015)

Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor
por: Lisman, Ton, et al.
Publicado: (2021)

Inhibition of Intrinsic Thrombin Generation
por: Stief, Thomas W.
Publicado: (2006)

Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis
por: Santamaria, Salvatore, et al.
Publicado: (2019)

Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10
por: Minond, Dmitriy
Publicado: (2020)

Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo
por: Botkjaer, Kenneth A., et al.
Publicado: (2016)

Thrombin–Fibrinogen In Vitro Flow Model of Thrombus Growth in Cerebral Aneurysms
por: Ngoepe, Malebogo N., et al.
Publicado: (2021)

Brachial pseudoaneurysm of the neonate with partial response to thrombin injections and late spontaneous thrombosis and regression during expectant management
por: Parra, Dimitri, et al.
Publicado: (2016)

Zebrafish thrombosis models according to the location of thrombus formation
por: Hwang, Jinwook, et al.
Publicado: (2023)

Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization
Publicado: (1993)

Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions
por: Derszniak, Katarzyna, et al.
Publicado: (2019)

Inhibition of thrombin, an unexplored function of retinoic acid()
por: Anantha Krishna, Tirumala Harikrishna, et al.
Publicado: (2019)

The C-terminal domains of ADAMTS1 contain exosites involved in its proteoglycanase activity
por: Minns, Alexander Frederick, et al.
Publicado: (2023)

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
por: Wilson, Simon J., et al.
Publicado: (2018)

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies
por: Brahmer, Julie R., et al.
Publicado: (2020)

Targeting Platelet Thrombin Receptor Signaling to Prevent Thrombosis
por: Wallace, Eric L., et al.
Publicado: (2013)

PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury
por: Holmes-Hampton, Gregory P., et al.
Publicado: (2023)

The utility of zebrafish thrombosis models in determining the location of thrombus formation
por: Chowdhury, Debkumar
Publicado: (2023)

Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019)

Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase
por: Shiryaev, Sergey A., et al.
Publicado: (2012)

Probing BoNT/A Protease Exosites: Implications for Inhibitor Design and Light Chain Longevity
por: Xue, Song, et al.
Publicado: (2014)

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
por: Madoux, Franck, et al.
Publicado: (2016)

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
por: Seanoon, Karnsasin, et al.
Publicado: (2022)

Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
por: Salvadore, Giacomo, et al.
Publicado: (2020)

Visualizing thrombosis to improve thrombus resolution
por: Weisel, John W., et al.
Publicado: (2021)

Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment
por: Alexander, Eric T., et al.
Publicado: (2016)

Chlorogenic Acid Inhibits Human Platelet Activation and Thrombus Formation
por: Fuentes, Eduardo, et al.
Publicado: (2014)

Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function
por: Liang, Ming-Lu, et al.
Publicado: (2015)

The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
por: Ampofo, Emmanuel, et al.
Publicado: (2020)

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xue, Xiaohua, et al.
Publicado: (2021)

Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821)
por: Kumar, Vidya P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qupau78uqcl54h3iodj9guh9j4